Akut Demiyelizan Sendrom ve Ayırıcı Tanısı

Solmaz İ.Akut demiyelinizan sendrom ve ayırıcı tanısı. In: Canpolat M, editor. Nöroimmünoloji 1st ed. Ankara: Türkiye Klinikleri; 2023. p. 25-30.

Duignan SM, Hemingway CA. Paediatric acquired demyelinating syndromes. Paediatrics and Child Health. 2019;29(11):468-75. doi:10.1016/j.paed.2019.07.010

Narula S, Banwell B. Pediatric Demyelination. Continuum (Minneapolis, Minn.). 2016;22(3):897–915. doi:10.1212/CON.0000000000000326.

O'Mahony J, Bar-Or A, Arnold DL, Sadovnick AD, Marrie RA, Banwell B, et al. Masquerades of acquired demyelination in children: experiences of a national demyelinating disease program. J Child Neurol. 2013;28(2):184–197. doi:10.1177/0883073812443006

Benseler S, Pohl D. Childhood central nervous system vasculitis. Handb Clin Neurol. 2013;112:1065-78. doi: 10.1016/B978-0-444-52910-7.00024-6. PMID: 23622312.

Yaari R, Anselm IA, Szer IS, Malicki DM, Nespeca MP, Gleeson JG. Childhood primary angiitis of the central nervous system: two biopsy-proven cases. J Pediatr. 2004 Nov;145(5):693-7. doi: 10.1016/j.jpeds.2004.06.076. PMID: 15520782.

Benseler SM, deVeber G, Hawkins C, Schneider R, Tyrrell PN, Aviv RI, et al. Angiography-negative primary central nervous system vasculitis in children: a newly recognized inflammatory central nervous system disease. Arthritis Rheum. 2005 Jul;52(7):2159-67. doi: 10.1002/art.21144. PMID: 15986347.

Hung SC, Guimaraes C. Imaging of Childhood Cerebral Vasculitis. Neuroimaging Clin N Am. 2024 Feb;34(1):149-166. doi: 10.1016/j.nic.2023.07.005. Epub 2023 Oct 8. PMID: 37951700.

Twilt M, Benseler SM. CNS vasculitis in children. Mult Scler Relat Disord. 2013 Jul;2(3):162-71. doi: 10.1016/j.msard.2012.11.002. Epub 2013 Jan 10. PMID: 25877722.

Soybilgic A. Neuropsychiatric Systemic Lupus Erythematosus in Children. Pediatr Ann. 2015 Jun;44(6). doi: 10.3928/00904481-20150611-11. PMID: 26114371.

Benseler SM, Silverman ED. Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus. 2007;16(8):564-71. doi: 10.1177/0961203307078971. PMID: 17711889.

Muscal E, Brey RL. Neurologic manifestations of systemic lupus erythematosus in children and adults. Neurol Clin. 2010 Feb;28(1):61-73. doi: 10.1016/j.ncl.2009.09.004. PMID: 19932376; PMCID: PMC2981505.

Harel L, Sandborg C, Lee T, von Scheven E. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol. 2006 Sep;33(9):1873-7. PMID: 16845706.

Yu HH, Lee JH, Wang LC, Yang YH, Chiang BL. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study. Lupus. 2006;15(10):651-7. doi: 10.1177/0961203306070990. Erratum in: Lupus. 2007;16(3):232. PMID: 17120591.

Olfat MO, Al-Mayouf SM, Muzaffer MA. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus. Clin Rheumatol. 2004 Oct;23(5):395-9. doi: 10.1007/s10067-004-0898-3. Epub 2004 Jul 23. PMID: 15278752.

Pozzato M, Dilena R, Rogani G, Beretta G, Torreggiani S, Lanni S, et al. Can early-onset acquired demyelinating syndrome (ADS) hide pediatric Behcet's disease? A case report. Front Pediatr. 2023 Jun 23;11:1175584. doi: 10.3389/fped.2023.1175584. PMID: 37425262; PMCID: PMC10327559.

Koné-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, et al.; PEDBD group. Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016 Jun;75(6):958-64. doi: 10.1136/annrheumdis-2015-208491. Epub 2015 Dec 23. PMID: 26698843.

Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, et al. A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry. Pediatr Rheumatol Online J. 2017 Dec 21;15(1):84. doi: 10.1186/s12969-017-0213-x. Erratum in: Pediatr Rheumatol Online J. 2018 Apr 23;16(1):29. doi: 10.1186/s12969-018-0241-1. PMID: 29268757; PMCID: PMC5740899.

Koné-Paut I. Behçet's disease in children, an overview. Pediatr Rheumatol Online J. 2016 Feb 18;14(1):10. doi: 10.1186/s12969-016-0070-z. PMID: 26887984; PMCID: PMC4758175.

Mora P, Menozzi C, Orsoni JG, Rubino P, Ruffini L, Carta A. Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features. Orphanet J Rare Dis. 2013 Jan 29;8:18. doi: 10.1186/1750-1172-8-18. PMID: 23360593; PMCID: PMC3567996.

Topcuoglu OM, Topcuoglu ED, Altay CM, Genc S. Imaging pearls of pediatric Behçet's disease. Eur J Radiol. 2017 Sep;94:115-124. doi: 10.1016/j.ejrad.2017.06.016. Epub 2017 Jun 28. PMID: 28712694.

Baumann RJ, Robertson WC Jr. Neurosarcoid presents differently in children than in adults. Pediatrics. 2003 Dec;112(6 Pt 1). doi: 10.1542/peds.112.6.e480. PMID: 14654650.

Nowak DA, Widenka DC. Neurosarcoidosis: a review of its intracranial manifestation. J Neurol. 2001 May;248(5):363-72. doi: 10.1007/s004150170175. PMID: 11437156.

Rao R, Dimitriades VR, Weimer M, Sandlin C. Neurosarcoidosis in Pediatric Patients: A Case Report and Review of Isolated and Systemic Neurosarcoidosis. Pediatr Neurol. 2016 Oct;63:45-52. doi: 10.1016/j.pediatrneurol.2016.05.018. Epub 2016 Jun 27. PMID: 27524272

Lury KM, Smith JK, Matheus MG, Castillo M. Neurosarcoidosis--review of imaging findings. Semin Roentgenol. 2004 Oct;39(4):495-504. doi: 10.1016/j.ro.2004.06.006. PMID: 15526533.

Ratai EM, Caruso P, Eichler F. Advances in MR Imaging of Leukodystrophies. InTech. 2012. doi: 10.5772/25151.

Weidauer S, Nichtweiss M, Hattingen E. Differential diagnosis of white matter lesions: Nonvascular causes-Part II. Clin Neuroradiol. 2014 Jun;24(2):93-110. doi: 10.1007/s00062-013-0267-1. Epub 2014 Feb 12. PMID: 24519493.

Macaron G, Samaan S, Cohen JA, Nadjar Y. Genetic findings in adolescent and adult-onset leukodystrophies with hypomyelinating features. J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):836-838. doi: 10.1136/jnnp-2018-319214. Epub 2018 Nov 2. PMID: 30389777.

Harris MO, Walsh LE, Hattab EM, Golomb MR. Is it ADEM, POLG, or both? Arch Neurol. 2010 Apr;67(4):493-6. doi: 10.1001/archneurol.2010.36. PMID: 20385918.

Della Marina A, Bertolini A, Wegener-Panzer A, Flotats-Bastardas M, Reinhardt T, El Naggar I, et al. Mitochondrial diseases mimicking autoimmune diseases of the CNS and good response to steroids initially. Eur J Paediatr Neurol. 2022 Nov;41:27-35. doi: 10.1016/j.ejpn.2022.09.003. Epub 2022 Sep 20. PMID: 36162141.

Ortigoza-Escobar JD, Alfadhel M, Molero-Luis M, Darin N, Spiegel R, de Coo IF, et al.; Thiamine Deficiency Study Group. Thiamine deficiency in childhood with attention to genetic causes: Survival and outcome predictors. Ann Neurol. 2017 Sep;82(3):317-330. doi: 10.1002/ana.24998. Epub 2017 Aug 30. PMID: 28856750.

Wu X, Wu W, Pan W, Wu L, Liu K, Zhang HL. Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder. Mediators Inflamm. 2015;2015:792578. doi: 10.1155/2015/792578. Epub 2015 Mar 22. PMID: 25873770; PMCID: PMC4385702.

Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev. 1997 Mar;19(2):81-92. doi: 10.1016/s0387-7604(96)00063-0. PMID: 9105653.

Rauer S, Kastenbauer S, Hofmann H, Fingerle V, Huppertz HI, Hunfeld KP, et al.; Consensus group. Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis. Ger Med Sci. 2020 Feb 27;18. doi: 10.3205/000279. PMID: 32341686; PMCID: PMC7174852.

Södermark L, Sigurdsson V, Näs W, Wall P, Trollfors B. Neuroborreliosis in Swedish Children: A Population-based Study on Incidence and Clinical Characteristics. Pediatr Infect Dis J. 2017 Nov;36(11):1052-1056. doi: 10.1097/INF.0000000000001653. PMID: 28654563.

Hansen K, Crone C, Kristoferitsch W. Lyme neuroborreliosis. Handb Clin Neurol. 2013;115:559-75. doi: 10.1016/B978-0-444-52902-2.00032-1. PMID: 23931802.

Skogman BH, Croner S, Nordwall M, Eknefelt M, Ernerudh J, Forsberg P. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr Infect Dis J. 2008 Dec;27(12):1089-94. doi: 10.1097/INF.0b013e31817fd423. PMID: 19008771.

Baumann M, Birnbacher R, Koch J, Strobl R, Rostásy K. Uncommon manifestations of neuroborreliosis in children. Eur J Paediatr Neurol. 2010 May;14(3):274-7. doi: 10.1016/j.ejpn.2009.08.003. Epub 2009 Sep 12. PMID: 19748808.

Krawczuk K, Czupryna P, Pancewicz S, Ołdak E, Król M, Moniuszko-Malinowska A. Comparison of Neuroborreliosis Between Children and Adults. Pediatr Infect Dis J. 2020 Jan;39(1):7-11. doi: 10.1097/INF.0000000000002493. PMID: 31815836.

Kan L, Sood SK, Maytal J. Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol. 1998 May;18(5):439-41. doi: 10.1016/s0887-8994(97)00215-4. PMID: 9650688.

Astrom KE, Mancall EL, Richardson EP Jr. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain. 1958 Mar;81(1):93-111. doi: 10.1093/brain/81.1.93. PMID: 13523006.

Richardson EP Jr. Progressive multifocal leukoencephalopathy. N Engl J Med. 1961 Oct 26;265:815-23. doi: 10.1056/NEJM196110262651701. PMID: 14038684.

Marshall LJ, Major EO. Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy. J Neuroimmune Pharmacol. 2010 Sep;5(3):404-17. doi: 10.1007/s11481-010-9203-1. Epub 2010 Apr 17. PMID: 20401541; PMCID: PMC3201779.

Berger JR, Houff S. Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol Res. 2006 Apr;28(3):299-305. doi: 10.1179/016164106X98198. PMID: 16687057

Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012 Jul;25(3):471-506. doi: 10.1128/CMR.05031-11. PMID: 22763635; PMCID: PMC3416490.

Trottestam H, Horne A, Aricò M, Egeler RM, Filipovich AH, Gadner H, et al.; Histiocyte Society. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011 Oct 27;118(17):4577-84. doi: 10.1182/blood-2011-06-356261. Epub 2011 Sep 6. PMID: 21900192; PMCID: PMC3208276.

Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood. 1997 Feb 1;89(3):794-800. PMID: 9028310.

Deiva K, Mahlaoui N, Beaudonnet F, de Saint Basile G, Caridade G, Moshous D, et al. CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology. 2012 Apr 10;78(15):1150-6. doi: 10.1212/WNL.0b013e31824f800a. Epub 2012 Mar 14. PMID: 22422896.

Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl). doi: 10.1016/j.bbmt.2009.11.014. Epub 2009 Nov 22. PMID: 19932759.

Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011 Oct 13;118(15):4041-52. doi: 10.1182/blood-2011-03-278127. Epub 2011 Aug 9. PMID: 21828139; PMCID: PMC3204727.

Jovanovic A, Kuzmanovic M, Kravljanac R, Micic D, Jovic M, Gazikalovic S, Pasic S. Central nervous system involvement in hemophagocytic lymphohistiocytosis: a single-center experience. Pediatr Neurol. 2014 Mar;50(3):233-7. doi: 10.1016/j.pediatrneurol.2013.10.014. Epub 2013 Nov 1. PMID: 24332871.

Henter JI, Nennesmo I. Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr. 1997 Mar;130(3):358-65. doi: 10.1016/s0022-3476(97)70196-3. PMID: 9063409.

Rostasy K, Bajer-Kornek B, Venkateswaran S, Hemingway C, Tardieu M. Differential diagnosis and evaluation in pediatric inflammatory demyelinating disorders. Neurology. 2016 Aug 30;87(9 Suppl 2). doi: 10.1212/WNL.0000000000002878. PMID: 27572858.

Abla O, Weitzman S, Blay JY, O'Neill BP, Abrey LE, Neuwelt E, et al. Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG). Clin Cancer Res. 2011 Jan 15;17(2):346-52. doi: 10.1158/1078-0432.CCR-10-1161. Epub 2011 Jan 11. PMID: 21224370; PMCID: PMC4058714.

Alper G. Acute disseminated encephalomyelitis. J Child Neurol. 2012 Nov;27(11):1408-25. doi: 10.1177/0883073812455104. Epub 2012 Aug 21. PMID: 22914374.

Santoro JD, Chitnis T. Diagnostic Considerations in Acute Disseminated Encephalomyelitis and the Interface with MOG Antibody. Neuropediatrics. 2019 Oct;50(5):273-279. doi: 10.1055/s-0039-1693152. Epub 2019 Jul 24. PMID: 31340401; PMCID: PMC7117081.

Filippi M, Rocca MA. Acute Disseminated Encephalomyelitis. White Matter Diseases. 2020 Feb 12:109–25. doi: 10.1007/978-3-030-38621-4_5. PMCID: PMC7121338.

Steiner I, Kennedy PG. Acute disseminated encephalomyelitis: current knowledge and open questions. J Neurovirol. 2015 Oct;21(5):473-9. doi: 10.1007/s13365-015-0353-z. Epub 2015 Jun 3. PMID: 26037112; PMCID: PMC7095407.

Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain. 2000 Dec;123 Pt 12:2407-22. doi: 10.1093/brain/123.12.2407. PMID: 11099444.

Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology. 2001 May 22;56(10):1308-12. doi: 10.1212/wnl.56.10.1308. PMID: 11376179.

Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology. 2002 Oct 22;59(8):1224-31. doi: 10.1212/wnl.59.8.1224. PMID: 12391351.

Wingerchuk DM. Postinfectious encephalomyelitis. Curr Neurol Neurosci Rep. 2003 May;3(3):256-64. doi: 10.1007/s11910-003-0086-x. PMID: 12691631.

Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al.; International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013 Sep;19(10):1261-7. doi: 10.1177/1352458513484547. Epub 2013 Apr 9. PMID: 23572237.

Baumann M, Sahin K, Lechner C, Hennes EM, Schanda K, Mader S, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):265-72. doi: 10.1136/jnnp-2014-308346. Epub 2014 Aug 13. PMID: 25121570.

Dale RC, Tantsis EM, Merheb V, Kumaran RY, Sinmaz N, Pathmanandavel K, et al. Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. Neurol Neuroimmunol Neuroinflamm. 2014 May 22;1(1). doi: 10.1212/NXI.0000000000000012. PMID: 25340056; PMCID: PMC4202678.

Chen Q, Zhao G, Huang Y, Li Z, Sun X, Lu P, et al. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study. Pediatr Neurol. 2018 Jun;83:42-49. doi: 10.1016/j.pediatrneurol.2018.03.003. Epub 2018 Mar 13. PMID: 29778487.

Narayan RN, McCreary M, Conger D, Wang C, Greenberg BM. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients. Mult Scler Relat Disord. 2019 Feb;28:86-90. doi: 10.1016/j.msard.2018.11.026. Epub 2018 Dec 15. PMID: 30576847.

Song H, Zhou H, Yang M, Tan S, Wang J, Xu Q, et al. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China. Br J Ophthalmol. 2019 Jun;103(6):831-836. doi: 10.1136/bjophthalmol-2018-312399. Epub 2018 Jul 26. PMID: 30049802.

Eyre M, Hameed A, Wright S, Brownlee W, Ciccarelli O, Bowman R, et al. Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome. Dev Med Child Neurol. 2018 Dec;60(12):1244-1250. doi: 10.1111/dmcn.13757. Epub 2018 Apr 11. PMID: 29637998.

Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, et al.; Australasian and New Zealand MOG Study Group. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):127-137. doi: 10.1136/jnnp-2017-316880. Epub 2017 Nov 15. PMID: 29142145; PMCID: PMC5800335.

Lock JH, Newman NJ, Biousse V, Peragallo JH. Update on pediatric optic neuritis. Curr Opin Ophthalmol. 2019 Nov;30(6):418-425. doi: 10.1097/ICU.0000000000000607. PMID: 31433309; PMCID: PMC8796206.

Ramanathan S, Prelog K, Barnes EH, Tantsis EM, Reddel SW, Henderson AP, et al. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler. 2016 Apr;22(4):470-82. doi: 10.1177/1352458515593406. Epub 2015 Jul 10. PMID: 26163068.

Wendel EM, Baumann M, Barisic N, Blaschek A, Coelho de Oliveira Koch E, Della Marina A, et al. High association of MOG-IgG antibodies in children with bilateral optic neuritis. Eur J Paediatr Neurol. 2020 Jul;27:86-93. doi: 10.1016/j.ejpn.2020.04.002. Epub 2020 Apr 15. PMID: 32327391.

Chen JJ, Bhatti MT. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Curr Opin Neurol. 2020 Feb;33(1):47-54. doi: 10.1097/WCO.0000000000000766. PMID: 31743235.

Song H, Zhou H, Yang M, Xu Q, Sun M, Wei S. Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: A cohort study in China. J Neurol Sci. 2019 May 15;400:83-89. doi: 10.1016/j.jns.2019.03.014. Epub 2019 Mar 16. PMID: 30904690.

Baumann M, Bartels F, Finke C, Adamsbaum C, Hacohen Y, Rostásy K; E.U. paediatric MOG consortium. E.U. paediatric MOG consortium consensus: Part 2 - Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020 Nov;29:14-21. doi: 10.1016/j.ejpn.2020.10.002. Epub 2020 Nov 4. PMID: 33158737.

Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, et al. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA Neurol. 2019 Mar 1;76(3):301-309. doi: 10.1001/jamaneurol.2018.4053. PMID: 30575890; PMCID: PMC6440233.

Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, et al.; BIOMARKER Study Group. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology. 2017 Aug 29;89(9):900-908. doi: 10.1212/WNL.0000000000004312. Epub 2017 Aug 2. PMID: 28768844.

Armangue T, Olivé-Cirera G, Martínez-Hernandez E, Sepulveda M, Ruiz-Garcia R, Muñoz-Batista M, et al.; Spanish Pediatric anti-MOG Study Group. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Lancet Neurol. 2020 Mar;19(3):234-246. doi: 10.1016/S1474-4422(19)30488-0. Epub 2020 Feb 10. Erratum in: Lancet Neurol. 2020 Apr;19(4). doi: 10.1016/S1474-4422(20)30074-0. PMID: 32057303.

Baumann M, Grams A, Djurdjevic T, Wendel EM, Lechner C, Behring B, et al. MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein. J Neurol. 2018 Apr;265(4):845-855. doi: 10.1007/s00415-018-8781-3. Epub 2018 Feb 8. PMID: 29423614.

Konuskan B, Yildirim M, Gocmen R, Okur TD, Polat I, Kilic H, et al. Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders. Mult Scler Relat Disord. 2018 Nov;26:1-7. doi: 10.1016/j.msard.2018.07.022. Epub 2018 Sep 10. PMID: 30212767.

Reindl M, Schanda K, Woodhall M, Tea F, Ramanathan S, Sagen J, et al. International multicenter examination of MOG antibody assays. Neurol Neuroimmunol Neuroinflamm. 2020 Feb 5;7(2). doi: 10.1212/NXI.0000000000000674. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2020 Mar 20;7(3). doi: 10.1212/NXI.0000000000000718. PMID: 32024795

Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019 Feb;15(2):89-102. doi: 10.1038/s41582-018-0112-x. PMID: 30559466.

Tea F, Lopez JA, Ramanathan S, Merheb V, Lee FXZ, Zou A, et al.; Australasian and New Zealand MOG Study Group. Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination. Acta Neuropathol Commun. 2019 Sep 3;7(1):145. doi: 10.1186/s40478-019-0786-3. PMID: 31481127; PMCID: PMC6724269.

Wegener-Panzer A, Cleaveland R, Wendel EM, Baumann M, Bertolini A, Häusler M, et al. Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies. Neurol Neuroimmunol Neuroinflamm. 2020 May 1;7(4). doi: 10.1212/NXI.0000000000000731. PMID: 32358225; PMCID: PMC7217659.

Gastaldi M, Scaranzin S, Jarius S, Wildeman B, Zardini E, Mallucci G, et al. Cell-based assays for the detection of MOG antibodies: a comparative study. J Neurol. 2020 Dec;267(12):3555-3564. doi: 10.1007/s00415-020-10024-0. Epub 2020 Jul 4. PMID: 32623596.

Akaishi T, Sato DK, Takahashi T, Nakashima I. Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein. Neurochem Int. 2019 Nov;130:104319. doi: 10.1016/j.neuint.2018.10.016. Epub 2018 Oct 23. PMID: 30365980.

Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, et al. A multicenter comparison of MOG-IgG cell-based assays. Neurology. 2019 Mar 12;92(11): PMC6511109.

Mariotto S, Gajofatto A, Batzu L, Delogu R, Sechi G, Leoni S, et al. Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases. Neurology. 2019 Nov 12;93(20). doi: 10.1212/WNL.0000000000008479. Epub 2019 Oct 23. PMID: 31645473.

Kwon YN, Kim B, Kim JS, Mo H, Choi K, Oh SI, et al. Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 28;9(1). doi: 10.1212/NXI.0000000000001095. PMID: 34711644; PMCID: PMC8554713.

Pace S, Orrell M, Woodhall M, Palace J, Leite MI, Irani SR, Waters P, Handel AE. Frequency of MOG-IgG in cerebrospinal fluid versus serum. J Neurol Neurosurg Psychiatry. 2022 Mar;93(3):334-335. doi: 10.1136/jnnp-2021-326779. Epub 2021 Jul 14. PMID: 34261747; PMCID: PMC8862025.

Waters P, Fadda G, Woodhall M, O'Mahony J, Brown RA, Castro DA, et al.; Canadian Pediatric Demyelinating Disease Network. Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes. JAMA Neurol. 2020 Jan 1;77(1):82-93. doi: 10.1001/jamaneurol.2019.2940. PMID: 31545352; PMCID: PMC6763982.

Banks SA, Morris PP, Chen JJ, Pittock SJ, Sechi E, Kunchok A, et al. Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry. 2020 Dec 28. doi: 10.1136/jnnp-2020-325121. Epub ahead of print. PMID: 33372052; PMCID: PMC8592388.

Lopez-Chiriboga AS, Sechi E, Buciuc M, Chen JJ, Pittock SJ, Lucchinetti CF, et al. Long-term Outcomes in Patients With Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disorder. JAMA Neurol. 2020 Dec 1;77(12):1575-1577. doi: 10.1001/jamaneurol.2020.3115. Erratum in: JAMA Neurol. 2021 Jun 1;78(6):765. doi: 10.1001/jamaneurol.2021.0783. PMID: 32865549; PMCID: PMC7489431.

Jarius S, Pellkofer H, Siebert N, Korporal-Kuhnke M, Hümmert MW, Ringelstein M, et al.; Neuromyelitis Optica Study Group (NEMOS). Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients. J Neuroinflammation. 2020 Sep 3;17(1):261. doi: 10.1186/s12974-020-01824-2. PMID: 32883348; PMCID: PMC7470615.

Hacohen Y, Absoud M, Deiva K, Hemingway C, Nytrova P, Woodhall M, et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children. Neurol Neuroimmunol Neuroinflamm. 2015 Mar 12;2(2). doi: 10.1212/NXI.0000000000000081. PMID: 25798445; PMCID: PMC4360800.

Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023 Mar;22(3):268-282. doi: 10.1016/S1474-4422(22)00431-8. Epub 2023 Jan 24. PMID: 36706773.

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al.; International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19. PMID: 26092914; PMCID: PMC4515040.

Pittock SJ, Lucchinetti CF. Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci. 2016 Feb;1366(1):20-39. doi: 10.1111/nyas.12794. Epub 2015 Jun 10. PMID: 26096370; PMCID: PMC4675706.

Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 Sep;6(9):805-15. doi: 10.1016/S1474-4422(07)70216-8. PMID: 17706564.

Tenembaum S, Chitnis T, Nakashima I, Collongues N, McKeon A, Levy M, Rostasy K. Neuromyelitis optica spectrum disorders in children and adolescents. Neurology. 2016 Aug 30;87(9 Suppl 2). doi: 10.1212/WNL.0000000000002824. PMID: 27572863.

Weinshenker BG, Wingerchuk DM. Neuromyelitis Spectrum Disorders. Mayo Clin Proc. 2017 Apr;92(4):663-679. doi: 10.1016/j.mayocp.2016.12.014. PMID: 28385199.

Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al.; Guthy-Jackson Charitable Foundation NMO International Clinical Consortium & Biorepository. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015 Mar 17;84(11):1165-73. doi: 10.1212/WNL.0000000000001367. Epub 2015 Feb 18. PMID: 25695963; PMCID: PMC4371410.

Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B. Neuromyelitis optica. Nat Rev Dis Primers. 2020 Oct 22;6(1):85. doi: 10.1038/s41572-020-0214-9. PMID: 33093467.

Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010 Aug;17(8):1019-32. doi: 10.1111/j.1468-1331.2010.03066.x. Epub 2010 Jun 7. PMID: 20528913.

Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 Mar;63(3):390-6. doi: 10.1001/archneur.63.3.390. PMID: 16533966.

Chan KH, Tse CT, Chung CP, Lee RL, Kwan JS, Ho PW, et al. Brain involvement in neuromyelitis optica spectrum disorders. Arch Neurol. 2011 Nov;68(11):1432-9. doi: 10.1001/archneurol.2011.249. PMID: 22084126.

Cabrera-Gómez JA, Quevedo-Sotolongo L, González-Quevedo A, Lima S, Real-González Y, Cristófol-Corominas M, et al. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica. Mult Scler. 2007 Mar;13(2):186-92. doi: 10.1177/1352458506070725. Epub 2007 Jan 29. PMID: 17439883.

Matthews L, Marasco R, Jenkinson M, Küker W, Luppe S, Leite MI, et al. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology. 2013 Apr 2;80(14):1330-7. doi: 10.1212/WNL.0b013e3182887957. Epub 2013 Mar 13. PMID: 23486868; PMCID: PMC3656462.

Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999 Sep 22;53(5):1107-14. doi: 10.1212/wnl.53.5.1107. PMID: 10496275.

Scott TF, Frohman EM, De Seze J, Gronseth GS, Weinshenker BG; Therapeutics and Technology Assessment Subcommittee of American Academy of Neurology. Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011 Dec 13;77(24):2128-34. doi: 10.1212/WNL.0b013e31823dc535. Epub 2011 Dec 7. PMID: 22156988.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. PMID: 29275977.

Zhang H, Verkman AS. Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. J Autoimmun. 2014 Sep;53:67-77. doi: 10.1016/j.jaut.2014.02.011. Epub 2014 Mar 31. PMID: 24698947; PMCID: PMC4162764.

Waters PJ, Pittock SJ, Bennett JL, Jarius S, Weinshenker BG, Wingerchuk DM. Evaluation of aquaporin-4 antibody assays. Clin Exp Neuroimmunol. 2014 Oct;5(3):290-303. doi: 10.1111/cen3.12107. Epub 2014 Apr 22. PMID: 27840658; PMCID: PMC5102503

Absoud M, Greenberg BM, Lim M, Lotze T, Thomas T, Deiva K. Pediatric transverse myelitis. Neurology. 2016 Aug 30;87(9 Suppl 2). doi: 10.1212/WNL.0000000000002820. PMID 27572861.

Wolf VL, Lupo PJ, Lotze TE. Pediatric acute transverse myelitis overview and differential diagnosis. J Child Neurol. 2012 Nov;27(11):1426-36. doi: 10.1177/0883073812452916. Epub 2012 Aug 21. PMID: 22914370.

Pidcock FS, Krishnan C, Crawford TO, Salorio CF, Trovato M, Kerr DA. Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology. 2007 May 1;68(18):1474-80. doi: 10.1212/01.wnl.0000260609.11357.6f. PMID: 17470749.

Thomas T, Branson HM, Verhey LH, Shroff M, Stephens D, Magalhaes S, et al. The demographic, clinical, and magnetic resonance imaging (MRI) features of transverse myelitis in children. J Child Neurol. 2012 Jan;27(1):11-21. doi: 10.1177/0883073811420495. Epub 2011 Oct 3. PMID: 21968984.

Sakakibara R, Hattori T, Yasuda K, Yamanishi T. Micturition disturbance in acute transverse myelitis. Spinal Cord. 1996 Aug;34(8):481-5. doi: 10.1038/sc.1996.82. PMID: 8856855.

Maynard FM Jr, Bracken MB, Creasey G, Ditunno JF Jr, Donovan WH, Ducker TB, et al. International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association. Spinal Cord. 1997 May;35(5):266-74. doi: 10.1038/sj.sc.3100432. PMID: 9160449.

Deiva K, Absoud M, Hemingway C, Hernandez Y, Hussson B, Maurey H, et al.; United Kingdom Childhood Inflammatory Demyelination (UK-CID) Study and French Kidbiosep Study. Acute idiopathic transverse myelitis in children: early predictors of relapse and disability. Neurology. 2015 Jan 27;84(4):341-9. doi: 10.1212/WNL.0000000000001179. Epub 2014 Dec 24. PMID: 25540303.

Alper G, Petropoulou KA, Fitz CR, Kim Y. Idiopathic acute transverse myelitis in children: an analysis and discussion of MRI findings. Mult Scler. 2011 Jan;17(1):74-80. doi: 10.1177/1352458510381393. Epub 2010 Sep 21. PMID: 20858691; PMCID: PMC3022414.

De Goede CG, Holmes EM, Pike MG. Acquired transverse myelopathy in children in the United Kingdom--a 2 year prospective study. Eur J Paediatr Neurol. 2010 Nov;14(6):479-87. doi: 10.1016/j.ejpn.2009.12.002. Epub 2010 Jan 25. PMID: 20089428.

Yiu EM, Kornberg AJ, Ryan MM, Coleman LT, Mackay MT. Acute transverse myelitis and acute disseminated encephalomyelitis in childhood: spectrum or separate entities? J Child Neurol. 2009 Mar;24(3):287-96. doi: 10.1177/0883073808323522. PMID: 19258287.

Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002 Aug 27;59(4):499-505. doi: 10.1212/wnl.59.4.499. PMID: 12236201.

Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D; University of British Columbia MS Clinic Neurologists. Early onset multiple sclerosis: a longitudinal study. Neurology. 2002 Oct 8;59(7):1006-10. doi: 10.1212/wnl.59.7.1006. PMID: 12370453.

Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B, et al.; Adult Neurology Departments KIDMUS Study Group. Natural history of multiple sclerosis with childhood onset. N Engl J Med. 2007 Jun 21;356(25):2603-13. doi: 10.1056/NEJMoa067597. PMID: 17582070.

Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol. 2009 Jan;66(1):54-9. doi: 10.1001/archneurol.2008.505. PMID: 19139299.

Waldman A, Ness J, Pohl D, Simone IL, Anlar B, Amato MP, et al. Pediatric multiple sclerosis: Clinical features and outcome. Neurology. 2016 Aug 30;87(9 Suppl 2). doi: 10.1212/WNL.0000000000003028. PMID: 27572865; PMCID: PMC10688072.

Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366. PMID: 21387374; PMCID: PMC3084507.

Huppke B, Ellenberger D, Rosewich H, Friede T, Gärtner J, Huppke P. Clinical presentation of pediatric multiple sclerosis before puberty. Eur J Neurol. 2014 Mar;21(3):441-6. doi: 10.1111/ene.12327. Epub 2013 Dec 16. PMID: 24330201.

Yeh EA, Weinstock-Guttman B, Ramanathan M, Ramasamy DP, Willis L, Cox JL, Zivadinov R. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain. 2009 Dec;132(Pt 12):3392-400. doi: 10.1093/brain/awp278. PMID: 19892770.

Jurkiewicz E, Kotulska K. Neuroimaging of multiple sclerosis in children. Neurol Neurochir Pol. 2011 Mar-Apr;45(2):152-60. Polish. doi: 10.1016/s0028-3843(14)60027-x. PMID: 21574120.

Dębska J, Kotulska-Józwiak K, Pawliszak P, Bilska M, Chmielewski D, Puzio I, Jurkiewicz E. Spinal cord lesions in children and adolescents with multiple sclerosis - Magnetic resonance imaging. Neurol Neurochir Pol. 2017 Jan-Feb;51(1):77-81. doi: 10.1016/j.pjnns.2016.11.008. Epub 2016 Dec 14. PMID: 28038775.

Bar-Or A, Hintzen RQ, Dale RC, Rostasy K, Brück W, Chitnis T. Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases. Neurology. 2016 Aug 30;87(9 Suppl 2). doi: 10.1212/WNL.0000000000002821. PMID: 27572856.

Marignier R, Hacohen Y, Cobo-Calvo A, Pröbstel AK, Aktas O, Alexopoulos H, et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021 Sep;20(9):762-772. doi: 10.1016/S1474-4422(21)00218-0. Erratum in: Lancet Neurol. 2021 Oct;20(10). doi: 10.1016/S1474-4422(21)00290-8. Erratum in: Lancet Neurol. 2022 Jan;21(1). doi: 10.1016/S1474-4422(21)00433-6. PMID: 344184

Boesen MS, Langkilde AR, Ilginiene J, Magyari M, Blinkenberg M. Oligoclonal bands, age 11-17 years, occipital lesion, and female sex differentiate pediatric multiple sclerosis from acute disseminated encephalomyelitis: A nationwide cohort study. Mult Scler Relat Disord. 2022 Oct;66:104008. doi: 10.1016/j.msard.2022.104008. Epub 2022 Jul 3. PMID: 35863128.

Boesen MS, Born AP, Jensen PEH, Sellebjerg F, Blinkenberg M, Lydolph MC, et al. Diagnostic Value of Oligoclonal Bands in Children: A Nationwide Population-Based Cohort Study. Pediatr Neurol. 2019 Aug;97:56-63. doi: 10.1016/j.pediatrneurol.2019.03.002. Epub 2019 Mar 13. PMID: 31060768.

Montalban X, Lebrun-Frenay C, Oh J, Arrambide G, Moccia M, Amato MP, et al. 2024 revisions of the McDonald criteria. Presented at: European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); 2024 Sep; København, Denmark.

Fadda G, Armangue T, Hacohen Y, Chitnis T, Banwell B. Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care. Lancet Neurol. 2021 Feb;20(2):136-149. doi: 10.1016/S1474-4422(20)30432-4. Epub 2021 Jan 20. PMID: 33484648.

Saini, L., & Sondhi, V. (2021). CNS autoimmunity in children: An unwanted wrinkle in a smooth narrative. Medical Journal Armed Forces India, 77(2), 138–146. https://doi.org/10.1016/j.mjafi.2021.03.005